Global Zinc Finger Nuclease Technology Market
Global Zinc Finger Nuclease Technology Market

Zinc Finger Nuclease Technology Comprehensive Study by Application (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, Others), End-User (Biotechnology Companies, Pharmaceutical Companies, Hospital Laboratory and Diagnostic Laboratory, Academic and Research Institutes) Players and Region - Global Market Outlook to 2026

Zinc Finger Nuclease Technology Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Oct 2021 Edition 250 Pages 218 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Zinc Finger Nuclease Technology Market Overview:
Zinc finger nucleases are restriction enzymes that have been engineered to target specific DNA sequences within the genome. This machinery allows for a flexible approach to allele editing and gene therapy. In this section, we will look at the architecture of ZFNs as well as strategies for generating targeted changes within the genome.

Growth Drivers
  • The rise in the incidence of chronic diseases such as cardiovascular diseases, cancer, blood pressure, obesity, and others

Roadblocks
  • High cost

Opportunities
  • Growing development in ZEPs with new sequence specificities
  • Research and development for the development of new therapeutic agents to treat various disease conditions

Challenges
  • Human tissue culture cells


Competitive Landscape:
Companies in the market are concentrating on zinc finger nuclease technology. With the rapid development of ZEPs, nuclease technology has increased. The companies operating in this industry are heavily focusing on enhancing their market presence by product development, investing in research and development activities. And also adopting strategic activities like partnerships, mergers, and acquisitions will help them to sustain in the market and maintain their competitive edge. The vendor defines an alignment or fits between their capabilities and future growth opportunities. The United States and Europe are expected to maintain their geographical leadership due to their innate nature of developed healthcare infrastructure, adoption of advanced technology at an earlier stage as compared to developing economies.
Some of the key players profiled in the report are Applied Biological Materials, Inc. (Canada), Caribou Biosciences, Inc. (United States), Cellectis, Inc. (France), Editas Medicine (United States), GenScript Biotech Corporation (United States), Gilead Sciences, Inc. (United States), Horizon Discovery Group, PLC (United Kingdom), Intellia Therapeutics (United States), OriGene Technologies, Inc. (United States), PNA Bio, Inc. (United States) and Precision BioSciences (United States). Additionally, following companies can also be profiled that are part of our coverage like Sangamo Therapeutics Inc. (United States), Santa Cruz Biotechnology, Inc. (United States) and Thermo Fisher Scientific Inc. (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Zinc Finger Nuclease Technology market by 2026. Considering Market by End-User, the sub-segment i.e. Biotechnology Companies will boost the Zinc Finger Nuclease Technology market.

September 28, 2021: Thermo Fisher Scientific launched the Thermo Scientific SpeciMAX Stabilized Saliva Collection Kit, designed to safely collect saliva for research. and October 5, 2021: Thermo Fisher Scientific launched the MagMAX Wastewater Ultra Nucleic Acid Isolation Kit. This kit offers solutions for labs setting up new surveillance programs or incorporating SARS-CoV-2 testing into existing ones.

What Can be Explored with the Zinc Finger Nuclease Technology Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Zinc Finger Nuclease Technology Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Zinc Finger Nuclease Technology
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Zinc Finger Nuclease Technology market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Zinc Finger Nuclease Technology market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Research & Development, Manufacturers, Healthcare Centre and Healthcare Services.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Frequently Asked Questions (FAQ):

1. What is the growth rate predicted for the Global Zinc Finger Nuclease Technology Market?
The Zinc Finger Nuclease Technology market is expected to see a CAGR of % during projected year 2020 to 2026.

2. Who are the top performing companies in Zinc Finger Nuclease Technology Market?
Top performing companies in the Global Zinc Finger Nuclease Technology market are Applied Biological Materials, Inc. (Canada), Caribou Biosciences, Inc. (United States), Cellectis, Inc. (France), Editas Medicine (United States), GenScript Biotech Corporation (United States), Gilead Sciences, Inc. (United States), Horizon Discovery Group, PLC (United Kingdom), Intellia Therapeutics (United States), OriGene Technologies, Inc. (United States), PNA Bio, Inc. (United States) and Precision BioSciences (United States), to name a few.

3. What trending factors would impact Zinc Finger Nuclease Technology Market growth most?
"Rising development in the healthcare industry" is seen as one of major influencing trends for Zinc Finger Nuclease Technology Market during projected period 2020-2026.

Report Objectives / Segmentation Covered
By Application
  • Cell Line Engineering
  • Animal Genetic Engineering
  • Plant Genetic Engineering
  • Others
By End-User
  • Biotechnology Companies
  • Pharmaceutical Companies
  • Hospital Laboratory and Diagnostic Laboratory
  • Academic and Research Institutes

By Regions
  • South America
    • Brazil
    • Argentina
    • Chile
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Indonesia
    • Thailand
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Spain
    • Sweden
    • Belgium
    • Finland
    • Denmark
    • Russia
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The rise in the incidence of chronic diseases such as cardiovascular diseases, cancer, blood pressure, obesity, and others
    • 3.3. Market Challenges
      • 3.3.1. Human tissue culture cells
    • 3.4. Market Trends
      • 3.4.1. Rising development in the healthcare industry
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Zinc Finger Nuclease Technology, by Application, End-User and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Zinc Finger Nuclease Technology (Value)
      • 5.2.1. Global Zinc Finger Nuclease Technology by: Application (Value)
        • 5.2.1.1. Cell Line Engineering
        • 5.2.1.2. Animal Genetic Engineering
        • 5.2.1.3. Plant Genetic Engineering
        • 5.2.1.4. Others
      • 5.2.2. Global Zinc Finger Nuclease Technology by: End-User (Value)
        • 5.2.2.1. Biotechnology Companies
        • 5.2.2.2. Pharmaceutical Companies
        • 5.2.2.3. Hospital Laboratory and Diagnostic Laboratory
        • 5.2.2.4. Academic and Research Institutes
      • 5.2.3. Global Zinc Finger Nuclease Technology Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Chile
          • 5.2.3.1.4. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Singapore
          • 5.2.3.2.6. Indonesia
          • 5.2.3.2.7. Thailand
          • 5.2.3.2.8. Australia
          • 5.2.3.2.9. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Spain
          • 5.2.3.3.7. Sweden
          • 5.2.3.3.8. Belgium
          • 5.2.3.3.9. Finland
          • 5.2.3.3.10. Denmark
          • 5.2.3.3.11. Russia
          • 5.2.3.3.12. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Zinc Finger Nuclease Technology (Price)
  • 6. Zinc Finger Nuclease Technology: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Applied Biological Materials, Inc. (Canada)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Caribou Biosciences, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Cellectis, Inc. (France)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Editas Medicine (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. GenScript Biotech Corporation (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Gilead Sciences, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Horizon Discovery Group, PLC (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Intellia Therapeutics (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. OriGene Technologies, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. PNA Bio, Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Precision BioSciences (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Zinc Finger Nuclease Technology Sale, by Application, End-User and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Zinc Finger Nuclease Technology (Value)
      • 7.2.1. Global Zinc Finger Nuclease Technology by: Application (Value)
        • 7.2.1.1. Cell Line Engineering
        • 7.2.1.2. Animal Genetic Engineering
        • 7.2.1.3. Plant Genetic Engineering
        • 7.2.1.4. Others
      • 7.2.2. Global Zinc Finger Nuclease Technology by: End-User (Value)
        • 7.2.2.1. Biotechnology Companies
        • 7.2.2.2. Pharmaceutical Companies
        • 7.2.2.3. Hospital Laboratory and Diagnostic Laboratory
        • 7.2.2.4. Academic and Research Institutes
      • 7.2.3. Global Zinc Finger Nuclease Technology Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Chile
          • 7.2.3.1.4. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Singapore
          • 7.2.3.2.6. Indonesia
          • 7.2.3.2.7. Thailand
          • 7.2.3.2.8. Australia
          • 7.2.3.2.9. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Spain
          • 7.2.3.3.7. Sweden
          • 7.2.3.3.8. Belgium
          • 7.2.3.3.9. Finland
          • 7.2.3.3.10. Denmark
          • 7.2.3.3.11. Russia
          • 7.2.3.3.12. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Zinc Finger Nuclease Technology (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Zinc Finger Nuclease Technology: by Application(USD Million)
  • Table 2. Zinc Finger Nuclease Technology Cell Line Engineering , by Region USD Million (2015-2020)
  • Table 3. Zinc Finger Nuclease Technology Animal Genetic Engineering , by Region USD Million (2015-2020)
  • Table 4. Zinc Finger Nuclease Technology Plant Genetic Engineering , by Region USD Million (2015-2020)
  • Table 5. Zinc Finger Nuclease Technology Others , by Region USD Million (2015-2020)
  • Table 6. Zinc Finger Nuclease Technology: by End-User(USD Million)
  • Table 7. Zinc Finger Nuclease Technology Biotechnology Companies , by Region USD Million (2015-2020)
  • Table 8. Zinc Finger Nuclease Technology Pharmaceutical Companies , by Region USD Million (2015-2020)
  • Table 9. Zinc Finger Nuclease Technology Hospital Laboratory and Diagnostic Laboratory , by Region USD Million (2015-2020)
  • Table 10. Zinc Finger Nuclease Technology Academic and Research Institutes , by Region USD Million (2015-2020)
  • Table 11. South America Zinc Finger Nuclease Technology, by Country USD Million (2015-2020)
  • Table 12. South America Zinc Finger Nuclease Technology, by Application USD Million (2015-2020)
  • Table 13. South America Zinc Finger Nuclease Technology, by End-User USD Million (2015-2020)
  • Table 14. Brazil Zinc Finger Nuclease Technology, by Application USD Million (2015-2020)
  • Table 15. Brazil Zinc Finger Nuclease Technology, by End-User USD Million (2015-2020)
  • Table 16. Argentina Zinc Finger Nuclease Technology, by Application USD Million (2015-2020)
  • Table 17. Argentina Zinc Finger Nuclease Technology, by End-User USD Million (2015-2020)
  • Table 18. Chile Zinc Finger Nuclease Technology, by Application USD Million (2015-2020)
  • Table 19. Chile Zinc Finger Nuclease Technology, by End-User USD Million (2015-2020)
  • Table 20. Rest of South America Zinc Finger Nuclease Technology, by Application USD Million (2015-2020)
  • Table 21. Rest of South America Zinc Finger Nuclease Technology, by End-User USD Million (2015-2020)
  • Table 22. Asia Pacific Zinc Finger Nuclease Technology, by Country USD Million (2015-2020)
  • Table 23. Asia Pacific Zinc Finger Nuclease Technology, by Application USD Million (2015-2020)
  • Table 24. Asia Pacific Zinc Finger Nuclease Technology, by End-User USD Million (2015-2020)
  • Table 25. China Zinc Finger Nuclease Technology, by Application USD Million (2015-2020)
  • Table 26. China Zinc Finger Nuclease Technology, by End-User USD Million (2015-2020)
  • Table 27. Japan Zinc Finger Nuclease Technology, by Application USD Million (2015-2020)
  • Table 28. Japan Zinc Finger Nuclease Technology, by End-User USD Million (2015-2020)
  • Table 29. India Zinc Finger Nuclease Technology, by Application USD Million (2015-2020)
  • Table 30. India Zinc Finger Nuclease Technology, by End-User USD Million (2015-2020)
  • Table 31. South Korea Zinc Finger Nuclease Technology, by Application USD Million (2015-2020)
  • Table 32. South Korea Zinc Finger Nuclease Technology, by End-User USD Million (2015-2020)
  • Table 33. Singapore Zinc Finger Nuclease Technology, by Application USD Million (2015-2020)
  • Table 34. Singapore Zinc Finger Nuclease Technology, by End-User USD Million (2015-2020)
  • Table 35. Indonesia Zinc Finger Nuclease Technology, by Application USD Million (2015-2020)
  • Table 36. Indonesia Zinc Finger Nuclease Technology, by End-User USD Million (2015-2020)
  • Table 37. Thailand Zinc Finger Nuclease Technology, by Application USD Million (2015-2020)
  • Table 38. Thailand Zinc Finger Nuclease Technology, by End-User USD Million (2015-2020)
  • Table 39. Australia Zinc Finger Nuclease Technology, by Application USD Million (2015-2020)
  • Table 40. Australia Zinc Finger Nuclease Technology, by End-User USD Million (2015-2020)
  • Table 41. Rest of Asia-Pacific Zinc Finger Nuclease Technology, by Application USD Million (2015-2020)
  • Table 42. Rest of Asia-Pacific Zinc Finger Nuclease Technology, by End-User USD Million (2015-2020)
  • Table 43. Europe Zinc Finger Nuclease Technology, by Country USD Million (2015-2020)
  • Table 44. Europe Zinc Finger Nuclease Technology, by Application USD Million (2015-2020)
  • Table 45. Europe Zinc Finger Nuclease Technology, by End-User USD Million (2015-2020)
  • Table 46. Germany Zinc Finger Nuclease Technology, by Application USD Million (2015-2020)
  • Table 47. Germany Zinc Finger Nuclease Technology, by End-User USD Million (2015-2020)
  • Table 48. France Zinc Finger Nuclease Technology, by Application USD Million (2015-2020)
  • Table 49. France Zinc Finger Nuclease Technology, by End-User USD Million (2015-2020)
  • Table 50. Italy Zinc Finger Nuclease Technology, by Application USD Million (2015-2020)
  • Table 51. Italy Zinc Finger Nuclease Technology, by End-User USD Million (2015-2020)
  • Table 52. United Kingdom Zinc Finger Nuclease Technology, by Application USD Million (2015-2020)
  • Table 53. United Kingdom Zinc Finger Nuclease Technology, by End-User USD Million (2015-2020)
  • Table 54. Netherlands Zinc Finger Nuclease Technology, by Application USD Million (2015-2020)
  • Table 55. Netherlands Zinc Finger Nuclease Technology, by End-User USD Million (2015-2020)
  • Table 56. Spain Zinc Finger Nuclease Technology, by Application USD Million (2015-2020)
  • Table 57. Spain Zinc Finger Nuclease Technology, by End-User USD Million (2015-2020)
  • Table 58. Sweden Zinc Finger Nuclease Technology, by Application USD Million (2015-2020)
  • Table 59. Sweden Zinc Finger Nuclease Technology, by End-User USD Million (2015-2020)
  • Table 60. Belgium Zinc Finger Nuclease Technology, by Application USD Million (2015-2020)
  • Table 61. Belgium Zinc Finger Nuclease Technology, by End-User USD Million (2015-2020)
  • Table 62. Finland Zinc Finger Nuclease Technology, by Application USD Million (2015-2020)
  • Table 63. Finland Zinc Finger Nuclease Technology, by End-User USD Million (2015-2020)
  • Table 64. Denmark Zinc Finger Nuclease Technology, by Application USD Million (2015-2020)
  • Table 65. Denmark Zinc Finger Nuclease Technology, by End-User USD Million (2015-2020)
  • Table 66. Russia Zinc Finger Nuclease Technology, by Application USD Million (2015-2020)
  • Table 67. Russia Zinc Finger Nuclease Technology, by End-User USD Million (2015-2020)
  • Table 68. Rest of Europe Zinc Finger Nuclease Technology, by Application USD Million (2015-2020)
  • Table 69. Rest of Europe Zinc Finger Nuclease Technology, by End-User USD Million (2015-2020)
  • Table 70. MEA Zinc Finger Nuclease Technology, by Country USD Million (2015-2020)
  • Table 71. MEA Zinc Finger Nuclease Technology, by Application USD Million (2015-2020)
  • Table 72. MEA Zinc Finger Nuclease Technology, by End-User USD Million (2015-2020)
  • Table 73. Middle East Zinc Finger Nuclease Technology, by Application USD Million (2015-2020)
  • Table 74. Middle East Zinc Finger Nuclease Technology, by End-User USD Million (2015-2020)
  • Table 75. Africa Zinc Finger Nuclease Technology, by Application USD Million (2015-2020)
  • Table 76. Africa Zinc Finger Nuclease Technology, by End-User USD Million (2015-2020)
  • Table 77. North America Zinc Finger Nuclease Technology, by Country USD Million (2015-2020)
  • Table 78. North America Zinc Finger Nuclease Technology, by Application USD Million (2015-2020)
  • Table 79. North America Zinc Finger Nuclease Technology, by End-User USD Million (2015-2020)
  • Table 80. United States Zinc Finger Nuclease Technology, by Application USD Million (2015-2020)
  • Table 81. United States Zinc Finger Nuclease Technology, by End-User USD Million (2015-2020)
  • Table 82. Canada Zinc Finger Nuclease Technology, by Application USD Million (2015-2020)
  • Table 83. Canada Zinc Finger Nuclease Technology, by End-User USD Million (2015-2020)
  • Table 84. Mexico Zinc Finger Nuclease Technology, by Application USD Million (2015-2020)
  • Table 85. Mexico Zinc Finger Nuclease Technology, by End-User USD Million (2015-2020)
  • Table 86. Company Basic Information, Sales Area and Its Competitors
  • Table 87. Company Basic Information, Sales Area and Its Competitors
  • Table 88. Company Basic Information, Sales Area and Its Competitors
  • Table 89. Company Basic Information, Sales Area and Its Competitors
  • Table 90. Company Basic Information, Sales Area and Its Competitors
  • Table 91. Company Basic Information, Sales Area and Its Competitors
  • Table 92. Company Basic Information, Sales Area and Its Competitors
  • Table 93. Company Basic Information, Sales Area and Its Competitors
  • Table 94. Company Basic Information, Sales Area and Its Competitors
  • Table 95. Company Basic Information, Sales Area and Its Competitors
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Zinc Finger Nuclease Technology: by Application(USD Million)
  • Table 98. Zinc Finger Nuclease Technology Cell Line Engineering , by Region USD Million (2021-2026)
  • Table 99. Zinc Finger Nuclease Technology Animal Genetic Engineering , by Region USD Million (2021-2026)
  • Table 100. Zinc Finger Nuclease Technology Plant Genetic Engineering , by Region USD Million (2021-2026)
  • Table 101. Zinc Finger Nuclease Technology Others , by Region USD Million (2021-2026)
  • Table 102. Zinc Finger Nuclease Technology: by End-User(USD Million)
  • Table 103. Zinc Finger Nuclease Technology Biotechnology Companies , by Region USD Million (2021-2026)
  • Table 104. Zinc Finger Nuclease Technology Pharmaceutical Companies , by Region USD Million (2021-2026)
  • Table 105. Zinc Finger Nuclease Technology Hospital Laboratory and Diagnostic Laboratory , by Region USD Million (2021-2026)
  • Table 106. Zinc Finger Nuclease Technology Academic and Research Institutes , by Region USD Million (2021-2026)
  • Table 107. South America Zinc Finger Nuclease Technology, by Country USD Million (2021-2026)
  • Table 108. South America Zinc Finger Nuclease Technology, by Application USD Million (2021-2026)
  • Table 109. South America Zinc Finger Nuclease Technology, by End-User USD Million (2021-2026)
  • Table 110. Brazil Zinc Finger Nuclease Technology, by Application USD Million (2021-2026)
  • Table 111. Brazil Zinc Finger Nuclease Technology, by End-User USD Million (2021-2026)
  • Table 112. Argentina Zinc Finger Nuclease Technology, by Application USD Million (2021-2026)
  • Table 113. Argentina Zinc Finger Nuclease Technology, by End-User USD Million (2021-2026)
  • Table 114. Chile Zinc Finger Nuclease Technology, by Application USD Million (2021-2026)
  • Table 115. Chile Zinc Finger Nuclease Technology, by End-User USD Million (2021-2026)
  • Table 116. Rest of South America Zinc Finger Nuclease Technology, by Application USD Million (2021-2026)
  • Table 117. Rest of South America Zinc Finger Nuclease Technology, by End-User USD Million (2021-2026)
  • Table 118. Asia Pacific Zinc Finger Nuclease Technology, by Country USD Million (2021-2026)
  • Table 119. Asia Pacific Zinc Finger Nuclease Technology, by Application USD Million (2021-2026)
  • Table 120. Asia Pacific Zinc Finger Nuclease Technology, by End-User USD Million (2021-2026)
  • Table 121. China Zinc Finger Nuclease Technology, by Application USD Million (2021-2026)
  • Table 122. China Zinc Finger Nuclease Technology, by End-User USD Million (2021-2026)
  • Table 123. Japan Zinc Finger Nuclease Technology, by Application USD Million (2021-2026)
  • Table 124. Japan Zinc Finger Nuclease Technology, by End-User USD Million (2021-2026)
  • Table 125. India Zinc Finger Nuclease Technology, by Application USD Million (2021-2026)
  • Table 126. India Zinc Finger Nuclease Technology, by End-User USD Million (2021-2026)
  • Table 127. South Korea Zinc Finger Nuclease Technology, by Application USD Million (2021-2026)
  • Table 128. South Korea Zinc Finger Nuclease Technology, by End-User USD Million (2021-2026)
  • Table 129. Singapore Zinc Finger Nuclease Technology, by Application USD Million (2021-2026)
  • Table 130. Singapore Zinc Finger Nuclease Technology, by End-User USD Million (2021-2026)
  • Table 131. Indonesia Zinc Finger Nuclease Technology, by Application USD Million (2021-2026)
  • Table 132. Indonesia Zinc Finger Nuclease Technology, by End-User USD Million (2021-2026)
  • Table 133. Thailand Zinc Finger Nuclease Technology, by Application USD Million (2021-2026)
  • Table 134. Thailand Zinc Finger Nuclease Technology, by End-User USD Million (2021-2026)
  • Table 135. Australia Zinc Finger Nuclease Technology, by Application USD Million (2021-2026)
  • Table 136. Australia Zinc Finger Nuclease Technology, by End-User USD Million (2021-2026)
  • Table 137. Rest of Asia-Pacific Zinc Finger Nuclease Technology, by Application USD Million (2021-2026)
  • Table 138. Rest of Asia-Pacific Zinc Finger Nuclease Technology, by End-User USD Million (2021-2026)
  • Table 139. Europe Zinc Finger Nuclease Technology, by Country USD Million (2021-2026)
  • Table 140. Europe Zinc Finger Nuclease Technology, by Application USD Million (2021-2026)
  • Table 141. Europe Zinc Finger Nuclease Technology, by End-User USD Million (2021-2026)
  • Table 142. Germany Zinc Finger Nuclease Technology, by Application USD Million (2021-2026)
  • Table 143. Germany Zinc Finger Nuclease Technology, by End-User USD Million (2021-2026)
  • Table 144. France Zinc Finger Nuclease Technology, by Application USD Million (2021-2026)
  • Table 145. France Zinc Finger Nuclease Technology, by End-User USD Million (2021-2026)
  • Table 146. Italy Zinc Finger Nuclease Technology, by Application USD Million (2021-2026)
  • Table 147. Italy Zinc Finger Nuclease Technology, by End-User USD Million (2021-2026)
  • Table 148. United Kingdom Zinc Finger Nuclease Technology, by Application USD Million (2021-2026)
  • Table 149. United Kingdom Zinc Finger Nuclease Technology, by End-User USD Million (2021-2026)
  • Table 150. Netherlands Zinc Finger Nuclease Technology, by Application USD Million (2021-2026)
  • Table 151. Netherlands Zinc Finger Nuclease Technology, by End-User USD Million (2021-2026)
  • Table 152. Spain Zinc Finger Nuclease Technology, by Application USD Million (2021-2026)
  • Table 153. Spain Zinc Finger Nuclease Technology, by End-User USD Million (2021-2026)
  • Table 154. Sweden Zinc Finger Nuclease Technology, by Application USD Million (2021-2026)
  • Table 155. Sweden Zinc Finger Nuclease Technology, by End-User USD Million (2021-2026)
  • Table 156. Belgium Zinc Finger Nuclease Technology, by Application USD Million (2021-2026)
  • Table 157. Belgium Zinc Finger Nuclease Technology, by End-User USD Million (2021-2026)
  • Table 158. Finland Zinc Finger Nuclease Technology, by Application USD Million (2021-2026)
  • Table 159. Finland Zinc Finger Nuclease Technology, by End-User USD Million (2021-2026)
  • Table 160. Denmark Zinc Finger Nuclease Technology, by Application USD Million (2021-2026)
  • Table 161. Denmark Zinc Finger Nuclease Technology, by End-User USD Million (2021-2026)
  • Table 162. Russia Zinc Finger Nuclease Technology, by Application USD Million (2021-2026)
  • Table 163. Russia Zinc Finger Nuclease Technology, by End-User USD Million (2021-2026)
  • Table 164. Rest of Europe Zinc Finger Nuclease Technology, by Application USD Million (2021-2026)
  • Table 165. Rest of Europe Zinc Finger Nuclease Technology, by End-User USD Million (2021-2026)
  • Table 166. MEA Zinc Finger Nuclease Technology, by Country USD Million (2021-2026)
  • Table 167. MEA Zinc Finger Nuclease Technology, by Application USD Million (2021-2026)
  • Table 168. MEA Zinc Finger Nuclease Technology, by End-User USD Million (2021-2026)
  • Table 169. Middle East Zinc Finger Nuclease Technology, by Application USD Million (2021-2026)
  • Table 170. Middle East Zinc Finger Nuclease Technology, by End-User USD Million (2021-2026)
  • Table 171. Africa Zinc Finger Nuclease Technology, by Application USD Million (2021-2026)
  • Table 172. Africa Zinc Finger Nuclease Technology, by End-User USD Million (2021-2026)
  • Table 173. North America Zinc Finger Nuclease Technology, by Country USD Million (2021-2026)
  • Table 174. North America Zinc Finger Nuclease Technology, by Application USD Million (2021-2026)
  • Table 175. North America Zinc Finger Nuclease Technology, by End-User USD Million (2021-2026)
  • Table 176. United States Zinc Finger Nuclease Technology, by Application USD Million (2021-2026)
  • Table 177. United States Zinc Finger Nuclease Technology, by End-User USD Million (2021-2026)
  • Table 178. Canada Zinc Finger Nuclease Technology, by Application USD Million (2021-2026)
  • Table 179. Canada Zinc Finger Nuclease Technology, by End-User USD Million (2021-2026)
  • Table 180. Mexico Zinc Finger Nuclease Technology, by Application USD Million (2021-2026)
  • Table 181. Mexico Zinc Finger Nuclease Technology, by End-User USD Million (2021-2026)
  • Table 182. Research Programs/Design for This Report
  • Table 183. Key Data Information from Secondary Sources
  • Table 184. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Zinc Finger Nuclease Technology: by Application USD Million (2015-2020)
  • Figure 5. Global Zinc Finger Nuclease Technology: by End-User USD Million (2015-2020)
  • Figure 6. South America Zinc Finger Nuclease Technology Share (%), by Country
  • Figure 7. Asia Pacific Zinc Finger Nuclease Technology Share (%), by Country
  • Figure 8. Europe Zinc Finger Nuclease Technology Share (%), by Country
  • Figure 9. MEA Zinc Finger Nuclease Technology Share (%), by Country
  • Figure 10. North America Zinc Finger Nuclease Technology Share (%), by Country
  • Figure 11. Global Zinc Finger Nuclease Technology share by Players 2020 (%)
  • Figure 12. Global Zinc Finger Nuclease Technology share by Players (Top 3) 2020(%)
  • Figure 13. Global Zinc Finger Nuclease Technology share by Players (Top 5) 2020(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Applied Biological Materials, Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 16. Applied Biological Materials, Inc. (Canada) Revenue: by Geography 2020
  • Figure 17. Caribou Biosciences, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Caribou Biosciences, Inc. (United States) Revenue: by Geography 2020
  • Figure 19. Cellectis, Inc. (France) Revenue, Net Income and Gross profit
  • Figure 20. Cellectis, Inc. (France) Revenue: by Geography 2020
  • Figure 21. Editas Medicine (United States) Revenue, Net Income and Gross profit
  • Figure 22. Editas Medicine (United States) Revenue: by Geography 2020
  • Figure 23. GenScript Biotech Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 24. GenScript Biotech Corporation (United States) Revenue: by Geography 2020
  • Figure 25. Gilead Sciences, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Gilead Sciences, Inc. (United States) Revenue: by Geography 2020
  • Figure 27. Horizon Discovery Group, PLC (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 28. Horizon Discovery Group, PLC (United Kingdom) Revenue: by Geography 2020
  • Figure 29. Intellia Therapeutics (United States) Revenue, Net Income and Gross profit
  • Figure 30. Intellia Therapeutics (United States) Revenue: by Geography 2020
  • Figure 31. OriGene Technologies, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. OriGene Technologies, Inc. (United States) Revenue: by Geography 2020
  • Figure 33. PNA Bio, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. PNA Bio, Inc. (United States) Revenue: by Geography 2020
  • Figure 35. Precision BioSciences (United States) Revenue, Net Income and Gross profit
  • Figure 36. Precision BioSciences (United States) Revenue: by Geography 2020
  • Figure 37. Global Zinc Finger Nuclease Technology: by Application USD Million (2021-2026)
  • Figure 38. Global Zinc Finger Nuclease Technology: by End-User USD Million (2021-2026)
  • Figure 39. South America Zinc Finger Nuclease Technology Share (%), by Country
  • Figure 40. Asia Pacific Zinc Finger Nuclease Technology Share (%), by Country
  • Figure 41. Europe Zinc Finger Nuclease Technology Share (%), by Country
  • Figure 42. MEA Zinc Finger Nuclease Technology Share (%), by Country
  • Figure 43. North America Zinc Finger Nuclease Technology Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Applied Biological Materials, Inc. (Canada)
  • Caribou Biosciences, Inc. (United States)
  • Cellectis, Inc. (France)
  • Editas Medicine (United States)
  • GenScript Biotech Corporation (United States)
  • Gilead Sciences, Inc. (United States)
  • Horizon Discovery Group, PLC (United Kingdom)
  • Intellia Therapeutics (United States)
  • OriGene Technologies, Inc. (United States)
  • PNA Bio, Inc. (United States)
  • Precision BioSciences (United States)
Additional players considered in the study are as follows:
Sangamo Therapeutics Inc. (United States) , Santa Cruz Biotechnology, Inc. (United States) , Thermo Fisher Scientific Inc. (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation